Spyre Therapeutics, Inc. (SYRE)
69.42
-5.03
(-6.76%)
USD |
NASDAQ |
May 01, 16:00
71.09
+1.67
(+2.41%)
After-Hours: 20:00
Spyre Therapeutics Market Cap : 5.452B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tyra Biosciences, Inc. | 1.834B |
| Replimune Group, Inc. | 206.43M |
| Savara, Inc. | 1.048B |
| Regeneron Pharmaceuticals, Inc. | 73.54B |
| Agios Pharmaceuticals, Inc. | 1.675B |
Market Cap Related Metrics
| Price to Book Value | 9.746 |
| Price | 69.42 |
| Earnings Yield | -2.99% |